Syndax Pharmaceuticals, Inc. (SNDX)
24.64
+0.35
(+1.44%)
USD |
NASDAQ |
Apr 07, 16:00
25.50
+0.86
(+3.49%)
After-Hours: 20:00
Syndax Pharmaceuticals Total Assets (Quarterly) : 529.71M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 937.61M |
| Vera Therapeutics, Inc. | 735.30M |
| Biogen, Inc. | 29.44B |
| Johnson & Johnson | 199.21B |
| Tango Therapeutics, Inc. | 410.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 465.08M |
| Shareholders Equity (Quarterly) | 64.63M |
| Debt to Equity Ratio | 5.345 |
| Current Ratio | 4.396 |
| Net Debt Paydown Yield | -3.75% |